Results 101 to 110 of about 11,333 (226)
Summary A 2‐year‐old Arabian filly presented with acute onset grade 4/5 (AAEP) right forelimb lameness and hindlimb ataxia following a collision with another horse and subsequent fall. The right forelimb lameness was associated with marked scapulohumeral joint instability.
O. E. Newman, B. Dunkel, M. Perrier
wiley +1 more source
Air stacking and chest compression increase peak cough flow in patients with Duchenne muscular dystrophy [PDF]
OBJECTIVE: To evaluate cough efficiency using two manually-assisted cough techniques. METHODS: We selected 28 patients with Duchenne muscular dystrophy.
Brito, Magneide Fernandes +3 more
core +3 more sources
Utility of Far‐Field Potentials as a Biomarker of Neurodegeneration in Spinal Muscular Atrophy
ABSTRACT Introduction/Aims Far field potentials (FFP) have been proposed as a reliable neurophysiological prognostic biomarker in amyotrophic lateral sclerosis (ALS). This study evaluated the utility of ulnar nerve FFP as a robust research biomarker of lower motor neuron degeneration in spinal muscular atrophy (SMA).
Aicee Dawn Calma +9 more
wiley +1 more source
Nemo-like kinase is a novel regulator of spinal and bulbar muscular atrophy
Spinal and bulbar muscular atrophy (SBMA) is a progressive neuromuscular disease caused by polyglutamine expansion in the androgen receptor (AR) protein. Despite extensive research, the exact pathogenic mechanisms underlying SBMA remain elusive.
Tiffany W Todd +5 more
doaj +1 more source
Neurotoxic effects of androgens in spinal and bulbar muscular atrophy
Expansion of polyglutamine tracts in nine different genes causes selective neuronal degeneration through unknown mechanisms. Expansion of polyglutamine in the androgen receptor is responsible for spinal and bulbar muscular atrophy (SBMA), a neuromuscular disorder characterized by the loss of lower motor neurons in the brainstem and spinal cord.
Parodi, Sara, Pennuto, Maria
openaire +5 more sources
ABSTRACT Introduction/Aims Three disease‐modifying therapies are approved for individuals with spinal muscular atrophy (SMA); however, data concerning the combination of these therapies remain limited. This study aimed to evaluate the safety and efficacy of add‐on risdiplam in children who had experienced clinical deterioration despite gene therapy ...
Corinna Stoltenburg +4 more
wiley +1 more source
Congenital muscular dystrophy: from muscle to brain. [PDF]
Congenital muscular dystrophies (CMDs) are a wide group of muscular disorders that manifest with very early onset of muscular weakness, sometime associated to severe brain involvement.The histologic pattern of muscle anomalies is typical of dystrophic ...
Corsello G +7 more
core +1 more source
“Silent Echoes of the Day: Dream Content Analysis in Amyotrophic Lateral Sclerosis”
ALS reshapes waking life through motor decline, social withdrawal, loneliness, and altered body image. Consistent with the continuity hypothesis, these changes may persist in dreams. In 68 ALS outpatients, a 7‐night dream diary yielded 127 reports, coded with the Hall–Van de Castle system (DreamSAT).
Alessandro Bombaci +6 more
wiley +1 more source
Neuromuscular magnetic stimulation counteracts muscle decline in ALS patients: results of a randomized, double-blind, controlled study [PDF]
The aim of the study was to verify whether neuromuscular magnetic stimulation (NMMS) improves muscle function in spinal-onset amyotrophic lateral sclerosis (ALS) patients.
Cambieri, Chiara +15 more
core +1 more source
Preimplantation genetic diagnosis for spinal and bulbar muscular atrophy (SBMA)
X-linked spinal and bulbar muscular atrophy is characterized by adult onset motor neuron disease and results from a defect in the androgen receptor. The disease is caused by a dynamic mutation in the first exon of the androgen receptor gene, involving a CAG trinucleotide repeat.
Georgiou, Iannis +7 more
openaire +4 more sources

